510(k) device
Encore System
Siesta Medical, Inc. · Tongue Suspension System (ORY, Class II) · First FDA decision Jul 1, 2011, newest Dec 22, 2021Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
510(k) pathway
Device trials
20
Naming "Encore"
MAUDE reports
2,359
Brand "Encore", since 2015
PubMed studies
408
Mentioning "Encore"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- Encore System510(k)
K213159 · Decided Dec 22, 2021 · 85 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
- Encore System510(k)
K201238 · Decided Oct 2, 2020 · 148 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
- Encore System510(k)
K183310 · Decided May 9, 2019 · 161 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
- ENCORE SYSTEM510(k)
K133680 · Decided Mar 26, 2014 · 114 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
K121814 · Decided Nov 7, 2012 · 140 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
K121440 · Decided Dec 6, 2012 · 205 days after receipt
Device type: Tongue Suspension System (ORY) · Dentistry & Oral Surgery
Older decisions: K111179
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Encore", any status and sponsor, newest update first.
Cairo UniversityAcademic, hospital or other
NCT07338994 · 30 participants · Start Apr 10, 2025 · Primary completion Jul 20, 2025
Device: TENS; 1. Tekscan Walkway system · For: Cerebral Palsy (CP)
Sites: Giza, Egypt
- Encore PFO Closure Device - The PerFOrm TrialPivotal-lookingRecruiting
Encore Medical Inc.Not on our public-company list
NCT05537753 · 500 participants (planned) · Start Jul 12, 2023 · Primary completion Apr 2026
Device: Encore PFO closure device; FDA-approved PFO closure device · For: Patent Foramen Ovale; Cryptogenic Stroke
Sites: Little Rock, Arkansas; La Jolla, California; Tampa, Florida · 8 sites in all
- Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max) Encore Device in Mechanically Ventilated ChildrenStatus unknown
Boston Children's HospitalAcademic, hospital or other
NCT04482556 · 40 participants (planned) · Start Jan 1, 2020 · Primary completion Dec 1, 2024
Device: Q-NRG+ Indirect Calorimetry Device; V(max) Encore Indirect Calorimetry Device · For: Calorimetry, Indirect; Oxygen Consumption; Metabolism and 1 more
Sites: Boston, Massachusetts
Encore Medical, L.P.Not on our public-company list
NCT01005446 · 245 participants · Start Dec 2009 · Primary completion Aug 2017
Device: Encore Reverse Shoulder Prosthesis (RSP®) · For: Rotator Cuff Deficiency; Shoulder Arthropathy; Failed Shoulder Replacement
Sites: Redwood City, California; Bradenton, Florida; Fort Lauderdale, Florida · 10 sites in all
Philips RespironicsPublic (PHG)
NCT03748264 · 62 participants · Start Oct 21, 2013 · Primary completion May 27, 2014
Device: DreamMapper Application; DreamMapper Application with Therapist Assist · For: Sleep Disordered Breathing
Sites: Little Rock, Arkansas; Atlanta, Georgia; Indianapolis, Indiana · 5 sites in all
- FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I StudyStatus unknown
Joost DaemenAcademic, hospital or other
NCT04591938 · 50 participants (planned) · Start Oct 1, 2019 · Primary completion Jun 1, 2021
Device: Fantom Encore Bioresorbable scaffold implantation · For: Percutaneous Coronary Intervention; Myocardial Revascularization; Tomography, Optical Coherence
Sites: Genk, Belgium; Leuven, Belgium; Rotterdam, Netherlands
- Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency MicroneedlingStatus unknown
Aarhus University HospitalAcademic, hospital or other
NCT04252352 · 15 participants (planned) · Start Feb 2020 · Primary completion Oct 2020
Device: Ablative fractional CO2 laser resurfacing/Radio-frequency microneedling · For: Acne Scars - Mixed Atrophic and Hypertrophic
Sites: Copenhagen, Denmark
Medtronic - MITGPublic (MDT)
NCT01788085 · 0 participants · Start Aug 2013 · Primary completion Mar 2014
Device: Bravo pH monitoring procedure · For: Gastro Esophageal Reflux Disease
Sites: Haifa, Israel
Abidin, Michael, M.D.Individual
NCT02738112 · 30 participants (planned) · Start Mar 2016 · Primary completion Mar 2019
Device: Encore System · For: Obstructive Sleep Apnea
Sites: Alexandria, Virginia
Sheffield Teaching Hospitals NHS Foundation TrustAcademic, hospital or other
NCT03154450 · 19 participants · Start Jan 21, 2016 · Primary completion Apr 1, 2017
Device: EncoreAnywhere with data available to review; EncoreAnywhere with no data available to review · For: Motor Neuron Disease
Sites: Sheffield, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Encore", and for the whole product code for context.
This brand
2,359 reports: 2,177 malfunction, 179 injury, 2 death
Whole product code ORY
50 reports: 7 malfunction, 43 injury, 0 death
Newest reports for this brand
2182208-2026-61514 · Received Oct 26, 2026 · Event dated Oct 6, 2026
Device type: Programmer, Pacemaker (KRG)
Device problem as coded: Display or Visual Feedback Problem; Inadequate User Interface
Patient problem as coded: Shock
- CareLink Encore ProgrammerMalfunction
2182208-2026-61095 · Received Oct 23, 2026 · Event dated Sep 10, 2026
Device type: Programmer, Pacemaker (KRG)
Device problem as coded: Computer Software Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- CareLink Encore ProgrammerMalfunction
2182208-2026-60926 · Received Oct 22, 2026 · Event dated Oct 13, 2026
Device type: Programmer, Pacemaker (KRG)
Device problem as coded: Application Program Freezes or Fails to Launch
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Encore 26Malfunction
3005099803-2026-04187 · Received Oct 20, 2026 · Event dated Sep 23, 2026
Device type: Syringe, Balloon Inflation, Exempt (PTM)
Device problem as coded: Device Contamination with Chemical or Other Material
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Encore 26Malfunction
3005099803-2026-04188 · Received Oct 20, 2026 · Event dated Sep 22, 2026
Device type: Syringe, Balloon Inflation, Exempt (PTM)
Device problem as coded: Device Contamination with Chemical or Other Material
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Encore"[tiab]. The summary above synthesizes these.
- [Le VIH/sida est encore présent].
Money DM · J Obstet Gynaecol Can · 2022Editorial
- [Not Available].
Lurie A, Fink C, Gosselin G, et al. · Virologie (Montrouge) · 2022
- [Not Available].
Najjar I, Hadj Salem R, Hellara I, et al. · Ann Biol Clin (Paris) · 2022
- Encore.
Dixon MR · Behav Anal Pract · 2016Editorial
- [Not Available].
Quach Hiep TT, Creveuil C, de Jaecher S, et al. · Ann Biol Clin (Paris) · 2022
- Encore!
Warren JV · J Lab Clin Med · 1986Biography, Editorial
- [Not Available].
Das Neves Martins Pires PH, Marega A, Creagh JM · Afr J Prim Health Care Fam Med · 2018
- Encore! Encore!
Kerr N · Medsurg Nurs · 2011Editorial
- Encore! Encore!
Lazarus A · Physician Exec · 2014
- General histological woes: Encore. Tissues, please.
Neumann PE, Neumann EE · Clin Anat · 2023Review
- Unwelcome encore.
Reider B · Am J Sports Med · 2010Editorial
- Encore Café: An Innovative and Effective Congregate Nutrition Program.
Schultz S, Francis SL, Russell C, et al. · J Nutr Gerontol Geriatr · 2021Research Support, U.S. Gov't, Non-P.H.S.
Other devices of this type
Also filed under product code ORY.
- Prelude III Tongue Suspension SystemSiesta Medical, Inc. · 510(k) 2011
- Prelude II Tounge Suspension SystemSiesta Medical, Inc. · 510(k) 2010
- Siesta Medical, Inc., Prelude Tongue Suspension SystemSiesta Medical, Inc. · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.